Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 94.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.85% |
| Dec 31, 2025 | -854.24% |
| Sep 30, 2025 | -160.92% |
| Jun 30, 2025 | -54.64% |
| Mar 31, 2025 | -8,893.92% |
| Dec 31, 2024 | -60.26% |
| Sep 30, 2024 | -98.19% |
| Jun 30, 2024 | -140.48% |
| Mar 31, 2024 | 99.04% |
| Dec 31, 2023 | 110.86% |
| Sep 30, 2023 | 59.33% |
| Jun 30, 2023 | 54.68% |
| Mar 31, 2023 | -4,269.31% |
| Nov 30, 2019 | 79.06% |
| Aug 31, 2019 | -2,222.02% |
| May 31, 2019 | -86.31% |
| Feb 28, 2019 | -32.80% |
| Nov 30, 2018 | -345.83% |
| Aug 31, 2018 | 99.69% |
| May 31, 2018 | -1,699.24% |